Arabi Abdulrahman, Alqahtani Awad, Arafa Salah, Altamimi Omar, Altamimi Hasan, Jalala Salem Abu, Rafie Ihsan Mahmoud, Ali Mohammed Thamer, Hamid Tahir, Al-Hijji Mohammed, Alkhani Murad, Al-Balushi Sara, Al Suwaidi Jassim
Department of Cardiology and Cardiovascular Surgery, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Heart Views. 2020 Jul-Sep;21(3):161-165. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_159_20. Epub 2020 Oct 13.
The novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) outbreak has affected ST-elevation myocardial infarction (STEMI) care worldwide. Reports from China, Europa, and North America showed a significant decline in STEMI volume with a simultaneous increase in time from symptoms to hospital presentation.
The aim of the study was to study the effect of the SARS-CoV-2 outbreak on primary percutaneous coronary intervention (PPCI) volume performed for STEMI, symptom onset to hospital presentation time (symptom-to-door [S2D]), and door-to-balloon time (D2B) at the main nationwide PPCI center in Qatar.
A retrospective evaluation of prospectively collected quality improvement cardiac catheterization data in Qatar was performed. PPCI volume and S2D and D2B time during the outbreak from March 9, 2020, to May 14, 2020, were compared with that of the same period from the prior year and the period immediately preceding the outbreak.
Since the SARS-CoV-2 outbreak in Qatar, 137 PPCI procedures were performed. There was a 40% reduction in the volume of PPCI when compared with the period immediately preceding the outbreak and 16% reduction in volume when compared with that of the same period in 2019. The median S2D time was 115 min (interquartile range [IQR: 124]), which was not statistically different from that of the preceding period or the same period in 2019. D2B time during the outbreak increased by an average of 7 min when compared with that of the same period preceding the outbreak (median: 47 min [IQR: 28] during the outbreak vs. median: 40 min [IQR: 21] during the preceding period, = 0.016).
In a statewide PPCI program in Qatar, we observed a mild reduction in PPCI cases during the SARS-CoV-2 outbreak (16% when compared with the same period in 2019), with a modest increase in D2B time. PPCI can be performed effectively during the SARS-CoV-2 outbreak at very high-volume centers with the adoption of strict infection control measures. With proper training and monitoring, both target D2B and hospital staff safety can be achieved.
新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情已影响全球ST段抬高型心肌梗死(STEMI)的治疗。来自中国、欧洲和北美的报告显示,STEMI病例数量显著下降,同时症状出现到医院就诊的时间增加。
本研究旨在探讨SARS-CoV-2疫情对卡塔尔主要的全国性经皮冠状动脉介入治疗(PPCI)中心针对STEMI进行的PPCI手术量、症状出现到医院就诊时间(症状到入院时间[S2D])以及入院到球囊扩张时间(D2B)的影响。
对卡塔尔前瞻性收集的质量改进心脏导管插入术数据进行回顾性评估。将2020年3月9日至2020年5月14日疫情期间的PPCI手术量、S2D和D2B时间与上一年同期以及疫情爆发前的时间段进行比较。
自卡塔尔爆发SARS-CoV-2疫情以来,共进行了137例PPCI手术。与疫情爆发前的时间段相比,PPCI手术量减少了40%,与2019年同期相比减少了16%。S2D时间中位数为115分钟(四分位间距[IQR:124]),与前一时期或2019年同期相比无统计学差异。与疫情爆发前的同期相比,疫情期间的D2B时间平均增加了7分钟(疫情期间中位数:47分钟[IQR:28],前一时期中位数:40分钟[IQR:21],P = 0.016)。
在卡塔尔的一项全州范围的PPCI项目中,我们观察到在SARS-CoV-2疫情期间PPCI病例略有减少(与2019年同期相比减少16%),D2B时间略有增加。在SARS-CoV-2疫情期间,通过采取严格的感染控制措施,在高手术量中心可以有效地进行PPCI。通过适当的培训和监测,可以实现目标D2B时间并保障医院工作人员的安全。